Rank;Global Rank;Institution;Country;Sector
1;550;IMEC International;BEL;Companies
2;571;Novo Nordisk A/S;DNK;Companies
3;1005;Novartis, Switzerland;CHE;Companies
4;1110;SINTEF Group;NOR;Companies
5;1139;Novartis Institutes for Biomedical Research, Switzerland;CHE;Companies
6;1316;GlaxoSmithKline, United Kingdom;GBR;Companies
7;1421;BMW AG;DEU;Companies
8;1438;Hoffmann-La Roche, Ltd., Switzerland;CHE;Companies
9;1543;Bayer AG, Germany;DEU;Companies
10;1752;AstraZeneca, United Kingdom;GBR;Companies
11;1779;Hoffmann-La Roche, GmbH., Germany;DEU;Companies
12;1810;AstraZeneca, Sweden;SWE;Companies
13;1844;Eli Lilly and Company Ltd., United Kingdom;GBR;Companies
14;1936;Carl Zeiss AG;DEU;Companies
15;1946;Telecom Italia S.p.A.;ITA;Companies
16;2021;Fusion for Energy;ESP;Companies
17;2044;Novartis Farma, S.p.A., Italy;ITA;Companies
18;2070;GlaxoSmithKline, Belgium;BEL;Companies
19;2090;France Telecom, S.A.;FRA;Companies
20;2096;Sincrotrone Trieste;ITA;Companies
21;2123;Daimler AG;DEU;Companies
22;2297;Intesa Sanpaolo S.p.A.;ITA;Companies
23;2376;Electricite de France, S.A.;FRA;Companies
24;2515;Merck KGaA, Germany;DEU;Companies
25;2595;Sanofi-Aventis, Germany;DEU;Companies
26;2694;Robert Bosch GmbH;DEU;Companies
27;2723;Pfizer Inc., United Kingdom;GBR;Companies
28;2860;Renault, S.A.S.;FRA;Companies
29;3021;European XFEL GmbH;DEU;Companies
30;3050;Bruker Corp;DEU;Companies
31;4553;Atomic Weapons Establishment;GBR;Companies
32;4566;ARUP;GBR;Companies
33;4995;BMJ Group;GBR;Companies